Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan.
Phase of Trial: Phase III
Latest Information Update: 10 Oct 2012
At a glance
- Drugs Imidafenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Sponsors Ono Pharmaceutical
- 05 Nov 2010 New trial record.
- 06 Apr 2006 Planned patient number is 750 according to ClinicalTrials.gov.
- 06 Apr 2006 Company (Ono Pharmaceutical) added as trial sponsor and additional lead trial centre identified as reported by ClinicalTrials.gov.